Big Pharma Eyes Next Childhood Vaccine Cash Cow — mRNA Vaccines for RSV

Now that COVID vaccines have established mRNA technology as the “new frontier for vaccine development,” pharma giants have set their sights on an mRNA vaccine for respiratory syncytial virus (RSV) — which they hope to add to an already overburdened childhood vaccine schedule.